

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | leukocyte aggregation (GO:0070486) | 4.79571764 |
| 2 | germinal center formation (GO:0002467) | 4.56069332 |
| 3 | definitive hemopoiesis (GO:0060216) | 4.53303754 |
| 4 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.34032297 |
| 5 | cellular response to ethanol (GO:0071361) | 4.25862741 |
| 6 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.24900870 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.13196991 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.08973548 |
| 9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.90021910 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.84835649 |
| 11 | immunoglobulin mediated immune response (GO:0016064) | 3.83598384 |
| 12 | negative T cell selection (GO:0043383) | 3.72206500 |
| 13 | negative thymic T cell selection (GO:0045060) | 3.71035795 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.67816182 |
| 15 | mast cell activation (GO:0045576) | 3.65900266 |
| 16 | positive regulation by symbiont of host defense response (GO:0052509) | 3.55851997 |
| 17 | modulation by symbiont of host defense response (GO:0052031) | 3.55851997 |
| 18 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.55851997 |
| 19 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.55851997 |
| 20 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.55851997 |
| 21 | modulation by symbiont of host immune response (GO:0052553) | 3.55851997 |
| 22 | skin morphogenesis (GO:0043589) | 3.49741955 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 3.47787959 |
| 24 | regulation of B cell differentiation (GO:0045577) | 3.44982630 |
| 25 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.41759852 |
| 26 | macrophage differentiation (GO:0030225) | 3.41061508 |
| 27 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.41044710 |
| 28 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.41044710 |
| 29 | positive thymic T cell selection (GO:0045059) | 3.40453642 |
| 30 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.36710277 |
| 31 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.34274441 |
| 32 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.33780325 |
| 33 | cellular response to interleukin-15 (GO:0071350) | 3.33102338 |
| 34 | mature B cell differentiation (GO:0002335) | 3.31731233 |
| 35 | mature B cell differentiation involved in immune response (GO:0002313) | 3.29267555 |
| 36 | response to muramyl dipeptide (GO:0032495) | 3.26614004 |
| 37 | response to peptidoglycan (GO:0032494) | 3.26549133 |
| 38 | negative regulation of interleukin-12 production (GO:0032695) | 3.22580464 |
| 39 | cellular extravasation (GO:0045123) | 3.21130592 |
| 40 | myeloid cell activation involved in immune response (GO:0002275) | 3.19073271 |
| 41 | positive T cell selection (GO:0043368) | 3.18971982 |
| 42 | B cell mediated immunity (GO:0019724) | 3.17177850 |
| 43 | defense response to protozoan (GO:0042832) | 3.15057044 |
| 44 | negative regulation of phagocytosis (GO:0050765) | 3.13424414 |
| 45 | lymphoid progenitor cell differentiation (GO:0002320) | 3.11408457 |
| 46 | histone H3-K4 trimethylation (GO:0080182) | 3.10704700 |
| 47 | response to protozoan (GO:0001562) | 3.09953021 |
| 48 | B cell receptor signaling pathway (GO:0050853) | 3.09453491 |
| 49 | interferon-gamma production (GO:0032609) | 3.08375401 |
| 50 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.06599544 |
| 51 | detection of molecule of bacterial origin (GO:0032490) | 3.06236295 |
| 52 | response to interleukin-15 (GO:0070672) | 3.06145514 |
| 53 | neutrophil activation involved in immune response (GO:0002283) | 3.03722570 |
| 54 | macrophage activation involved in immune response (GO:0002281) | 3.03469046 |
| 55 | megakaryocyte development (GO:0035855) | 3.03415900 |
| 56 | T cell migration (GO:0072678) | 3.03411043 |
| 57 | detection of other organism (GO:0098543) | 3.00528561 |
| 58 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.99954705 |
| 59 | T cell selection (GO:0045058) | 2.98689180 |
| 60 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.98214728 |
| 61 | positive regulation of granulocyte differentiation (GO:0030854) | 2.97547265 |
| 62 | dendritic cell migration (GO:0036336) | 2.97257267 |
| 63 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.96035674 |
| 64 | positive regulation of interleukin-17 production (GO:0032740) | 2.95752090 |
| 65 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.95731069 |
| 66 | negative regulation of cell killing (GO:0031342) | 2.94520347 |
| 67 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.94520347 |
| 68 | regulation of interleukin-17 production (GO:0032660) | 2.94297649 |
| 69 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.90958219 |
| 70 | angiogenesis involved in wound healing (GO:0060055) | 2.90630896 |
| 71 | dendritic cell chemotaxis (GO:0002407) | 2.90543141 |
| 72 | detection of bacterium (GO:0016045) | 2.89758520 |
| 73 | mast cell activation involved in immune response (GO:0002279) | 2.88789820 |
| 74 | mast cell degranulation (GO:0043303) | 2.88789820 |
| 75 | response to type I interferon (GO:0034340) | 2.88379818 |
| 76 | type I interferon signaling pathway (GO:0060337) | 2.86754593 |
| 77 | cellular response to type I interferon (GO:0071357) | 2.86754593 |
| 78 | thymic T cell selection (GO:0045061) | 2.84414589 |
| 79 | negative regulation of type 2 immune response (GO:0002829) | 2.82926131 |
| 80 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.82135339 |
| 81 | detection of external biotic stimulus (GO:0098581) | 2.81980802 |
| 82 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.81913694 |
| 83 | response to host (GO:0075136) | 2.81842610 |
| 84 | response to host defenses (GO:0052200) | 2.81842610 |
| 85 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.81842610 |
| 86 | regulation of tolerance induction (GO:0002643) | 2.80400417 |
| 87 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.79365399 |
| 88 | regulation of mast cell activation (GO:0033003) | 2.78468289 |
| 89 | positive regulation of mast cell activation (GO:0033005) | 2.77606691 |
| 90 | B cell homeostasis (GO:0001782) | 2.76146335 |
| 91 | B cell differentiation (GO:0030183) | 2.75865024 |
| 92 | response to host immune response (GO:0052572) | 2.75682436 |
| 93 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.75682436 |
| 94 | respiratory burst (GO:0045730) | 2.75633877 |
| 95 | positive regulation of macrophage differentiation (GO:0045651) | 2.74640491 |
| 96 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.74582377 |
| 97 | T cell homeostasis (GO:0043029) | 2.72812448 |
| 98 | negative regulation of interleukin-17 production (GO:0032700) | 2.70847027 |
| 99 | positive regulation of tolerance induction (GO:0002645) | 2.70822863 |
| 100 | positive regulation of isotype switching (GO:0045830) | 2.70635407 |
| 101 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.70448767 |
| 102 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.70356856 |
| 103 | microglial cell activation (GO:0001774) | 2.69502173 |
| 104 | negative regulation of interleukin-8 production (GO:0032717) | 2.69486448 |
| 105 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.69393745 |
| 106 | positive regulation of mast cell degranulation (GO:0043306) | 2.69393745 |
| 107 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.69081503 |
| 108 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.68404178 |
| 109 | cellular defense response (GO:0006968) | 2.68044645 |
| 110 | positive regulation of interferon-alpha production (GO:0032727) | 2.66831023 |
| 111 | response to interferon-alpha (GO:0035455) | 2.66167574 |
| 112 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.66087985 |
| 113 | neutrophil activation (GO:0042119) | 2.65952785 |
| 114 | lymph node development (GO:0048535) | 2.64498313 |
| 115 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.63119705 |
| 116 | leukocyte cell-cell adhesion (GO:0007159) | 2.60451449 |
| 117 | RNA destabilization (GO:0050779) | 2.59923712 |
| 118 | negative regulation of T cell mediated immunity (GO:0002710) | 2.58951361 |
| 119 | positive regulation of B cell differentiation (GO:0045579) | 2.58384006 |
| 120 | superoxide anion generation (GO:0042554) | 2.54869207 |
| 121 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.54445367 |
| 122 | amyloid precursor protein catabolic process (GO:0042987) | 2.53886909 |
| 123 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.49216823 |
| 124 | myeloid dendritic cell activation (GO:0001773) | 2.49107249 |
| 125 | positive regulation of T cell chemotaxis (GO:0010820) | 2.48831643 |
| 126 | regulation of T cell chemotaxis (GO:0010819) | 2.48831643 |
| 127 | leukocyte homeostasis (GO:0001776) | 2.48296174 |
| 128 | positive regulation of DNA recombination (GO:0045911) | 2.47518702 |
| 129 | negative regulation of viral genome replication (GO:0045071) | 2.46520076 |
| 130 | energy homeostasis (GO:0097009) | 2.45018707 |
| 131 | regulation of necroptotic process (GO:0060544) | 2.44613118 |
| 132 | lymphocyte homeostasis (GO:0002260) | 2.43080730 |
| 133 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.40476902 |
| 134 | T cell activation involved in immune response (GO:0002286) | 2.40024401 |
| 135 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.39648527 |
| 136 | tolerance induction (GO:0002507) | 2.39110502 |
| 137 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.38445673 |
| 138 | myoblast migration (GO:0051451) | 2.38379811 |
| 139 | B cell activation (GO:0042113) | 2.37286911 |
| 140 | negative regulation of B cell activation (GO:0050869) | 2.37124951 |
| 141 | regulation of cellular extravasation (GO:0002691) | 2.36717641 |
| 142 | granulocyte activation (GO:0036230) | 2.35097838 |
| 143 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.34304647 |
| 144 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.34040939 |
| 145 | T-helper cell differentiation (GO:0042093) | 2.34040939 |
| 146 | polyketide metabolic process (GO:0030638) | 2.33098551 |
| 147 | doxorubicin metabolic process (GO:0044598) | 2.33098551 |
| 148 | daunorubicin metabolic process (GO:0044597) | 2.33098551 |
| 149 | embryonic hemopoiesis (GO:0035162) | 2.32784714 |
| 150 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.32313609 |
| 151 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.31786928 |
| 152 | leukocyte degranulation (GO:0043299) | 2.30958144 |
| 153 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.30955972 |
| 154 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.30366789 |
| 155 | positive regulation of odontogenesis (GO:0042482) | 2.30239084 |
| 156 | neutrophil mediated immunity (GO:0002446) | 2.30003913 |
| 157 | hepatocyte apoptotic process (GO:0097284) | 2.29716545 |
| 158 | negative regulation of B cell proliferation (GO:0030889) | 2.29505304 |
| 159 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.29335750 |
| 160 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.28925891 |
| 161 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.28025613 |
| 162 | regulation of mast cell degranulation (GO:0043304) | 2.27479907 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.28228850 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.41629782 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.35481463 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.14699487 |
| 5 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 3.33515182 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.06692848 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.03534566 |
| 8 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.97807664 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.70765136 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.47822810 |
| 11 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.45624498 |
| 12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.45017784 |
| 13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.43945746 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.40777481 |
| 15 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.36177052 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.33586128 |
| 17 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.13018845 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12900284 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.03121713 |
| 20 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.01552283 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.98415949 |
| 22 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.95304529 |
| 23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.91960154 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.84383650 |
| 25 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.83785077 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 1.81989398 |
| 27 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.80212338 |
| 28 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.76381600 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.76372504 |
| 30 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.72141074 |
| 31 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.72000992 |
| 32 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.71564805 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.69729331 |
| 34 | GATA3_26560356_Chip-Seq_TH2_Human | 1.68495820 |
| 35 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.65757220 |
| 36 | MYC_22102868_ChIP-Seq_BL_Human | 1.65094889 |
| 37 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.64484221 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.63241478 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.62405918 |
| 40 | TP53_16413492_ChIP-PET_HCT116_Human | 1.59281015 |
| 41 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.57487397 |
| 42 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57203128 |
| 43 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.55488616 |
| 44 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.54946127 |
| 45 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.54710892 |
| 46 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.52788288 |
| 47 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.52663655 |
| 48 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.52083987 |
| 49 | MYB_26560356_Chip-Seq_TH1_Human | 1.51691556 |
| 50 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50649095 |
| 51 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.48856575 |
| 52 | MAF_26560356_Chip-Seq_TH2_Human | 1.44298435 |
| 53 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.44170779 |
| 54 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.43281842 |
| 55 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.42991746 |
| 56 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.41356582 |
| 57 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.34548027 |
| 58 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.34392375 |
| 59 | SPI1_23127762_ChIP-Seq_K562_Human | 1.33880979 |
| 60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33312109 |
| 61 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.32172801 |
| 62 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.31882229 |
| 63 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.31521006 |
| 64 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.31316622 |
| 65 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.28788081 |
| 66 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.28395112 |
| 67 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.28056156 |
| 68 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.28004391 |
| 69 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.25886960 |
| 70 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.23788095 |
| 71 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.23205580 |
| 72 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.18333043 |
| 73 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.18294202 |
| 74 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18088958 |
| 75 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.17348403 |
| 76 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.16421691 |
| 77 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.14934517 |
| 78 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14452577 |
| 79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14263704 |
| 80 | MAF_26560356_Chip-Seq_TH1_Human | 1.13946816 |
| 81 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13341523 |
| 82 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.12016146 |
| 83 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.11109216 |
| 84 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10311274 |
| 85 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09939931 |
| 86 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.09540875 |
| 87 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.09029213 |
| 88 | FUS_26573619_Chip-Seq_HEK293_Human | 1.08365495 |
| 89 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.08003996 |
| 90 | P300_19829295_ChIP-Seq_ESCs_Human | 1.05979550 |
| 91 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04844199 |
| 92 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.04833289 |
| 93 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04039408 |
| 94 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03829247 |
| 95 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03793695 |
| 96 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.03640057 |
| 97 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.03582416 |
| 98 | EWS_26573619_Chip-Seq_HEK293_Human | 1.03160760 |
| 99 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02128265 |
| 100 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.01407514 |
| 101 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.01017126 |
| 102 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00392809 |
| 103 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00344286 |
| 104 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.99039869 |
| 105 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98954205 |
| 106 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.98915548 |
| 107 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.98804950 |
| 108 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98241819 |
| 109 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97798402 |
| 110 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.97764714 |
| 111 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97251229 |
| 112 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96659505 |
| 113 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.96630537 |
| 114 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95608980 |
| 115 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.95288769 |
| 116 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.95066039 |
| 117 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94973086 |
| 118 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.94721012 |
| 119 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94646776 |
| 120 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.93697677 |
| 121 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.93038135 |
| 122 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.92396099 |
| 123 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.91468258 |
| 124 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90797802 |
| 125 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90777544 |
| 126 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90531224 |
| 127 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89779523 |
| 128 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.89494761 |
| 129 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.88321664 |
| 130 | UTX_26944678_Chip-Seq_JUKART_Human | 0.87919398 |
| 131 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.87351122 |
| 132 | CJUN_26792858_Chip-Seq_BT549_Human | 0.86470103 |
| 133 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.86367811 |
| 134 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86250499 |
| 135 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85675266 |
| 136 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.84929658 |
| 137 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.84858599 |
| 138 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84654163 |
| 139 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84173138 |
| 140 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.84061324 |
| 141 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.82820136 |
| 142 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.82520446 |
| 143 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82210560 |
| 144 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.81972848 |
| 145 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.81392916 |
| 146 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.79396053 |
| 147 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.78821408 |
| 148 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.78821408 |
| 149 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76085707 |
| 150 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.74734496 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006054_spinal_hemorrhage | 3.75855119 |
| 2 | MP0002396_abnormal_hematopoietic_system | 3.35259162 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.24377869 |
| 4 | MP0005174_abnormal_tail_pigmentation | 2.67836926 |
| 5 | MP0005671_abnormal_response_to | 2.58893095 |
| 6 | MP0000685_abnormal_immune_system | 2.49975852 |
| 7 | MP0000569_abnormal_digit_pigmentation | 2.45016092 |
| 8 | MP0005409_darkened_coat_color | 2.28689429 |
| 9 | MP0003436_decreased_susceptibility_to | 2.25917368 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.25857307 |
| 11 | MP0009785_altered_susceptibility_to | 2.21714712 |
| 12 | MP0002419_abnormal_innate_immunity | 2.21426525 |
| 13 | MP0002009_preneoplasia | 2.20240857 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.17760188 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.15962373 |
| 16 | MP0005025_abnormal_response_to | 2.15746797 |
| 17 | MP0001800_abnormal_humoral_immune | 2.15462697 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.09582931 |
| 19 | MP0002723_abnormal_immune_serum | 2.08455720 |
| 20 | MP0001819_abnormal_immune_cell | 2.08445995 |
| 21 | MP0004808_abnormal_hematopoietic_stem | 2.07015261 |
| 22 | MP0000015_abnormal_ear_pigmentation | 2.05333420 |
| 23 | MP0005503_abnormal_tendon_morphology | 2.03625548 |
| 24 | MP0001790_abnormal_immune_system | 2.02237562 |
| 25 | MP0005387_immune_system_phenotype | 2.02237562 |
| 26 | MP0006082_CNS_inflammation | 1.99324139 |
| 27 | MP0002166_altered_tumor_susceptibility | 1.97539240 |
| 28 | MP0002933_joint_inflammation | 1.82423087 |
| 29 | * MP0002398_abnormal_bone_marrow | 1.81396832 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.75558421 |
| 31 | MP0002006_tumorigenesis | 1.75411265 |
| 32 | MP0003279_aneurysm | 1.71165936 |
| 33 | * MP0000716_abnormal_immune_system | 1.69094176 |
| 34 | MP0001851_eye_inflammation | 1.67261640 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.65479744 |
| 36 | MP0003763_abnormal_thymus_physiology | 1.64807410 |
| 37 | MP0000465_gastrointestinal_hemorrhage | 1.63013501 |
| 38 | MP0008438_abnormal_cutaneous_collagen | 1.60433402 |
| 39 | * MP0002998_abnormal_bone_remodeling | 1.57746548 |
| 40 | MP0009764_decreased_sensitivity_to | 1.57560380 |
| 41 | MP0001873_stomach_inflammation | 1.50112080 |
| 42 | MP0002095_abnormal_skin_pigmentation | 1.49871819 |
| 43 | MP0002405_respiratory_system_inflammati | 1.47935891 |
| 44 | MP0003724_increased_susceptibility_to | 1.47848444 |
| 45 | * MP0002722_abnormal_immune_system | 1.42191177 |
| 46 | MP0000858_altered_metastatic_potential | 1.38932460 |
| 47 | MP0001188_hyperpigmentation | 1.37261597 |
| 48 | MP0003303_peritoneal_inflammation | 1.36870517 |
| 49 | MP0003787_abnormal_imprinting | 1.35397238 |
| 50 | * MP0000703_abnormal_thymus_morphology | 1.33783005 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.33466564 |
| 52 | * MP0000689_abnormal_spleen_morphology | 1.31430709 |
| 53 | * MP0002429_abnormal_blood_cell | 1.30853424 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.29581154 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.29581154 |
| 56 | MP0001853_heart_inflammation | 1.28972738 |
| 57 | MP0009384_cardiac_valve_regurgitation | 1.26185997 |
| 58 | MP0003448_altered_tumor_morphology | 1.26069683 |
| 59 | MP0004510_myositis | 1.25779124 |
| 60 | MP0003866_abnormal_defecation | 1.25488504 |
| 61 | MP0002249_abnormal_larynx_morphology | 1.25220177 |
| 62 | MP0005075_abnormal_melanosome_morpholog | 1.23828239 |
| 63 | MP0010155_abnormal_intestine_physiology | 1.22519446 |
| 64 | * MP0009250_abnormal_appendicular_skeleto | 1.20764971 |
| 65 | MP0003172_abnormal_lysosome_physiology | 1.13907339 |
| 66 | MP0004947_skin_inflammation | 1.13088082 |
| 67 | MP0003183_abnormal_peptide_metabolism | 1.12880628 |
| 68 | MP0003075_altered_response_to | 1.10041743 |
| 69 | MP0009278_abnormal_bone_marrow | 1.09777175 |
| 70 | * MP0005390_skeleton_phenotype | 1.09208441 |
| 71 | MP0001845_abnormal_inflammatory_respons | 1.08560118 |
| 72 | * MP0003795_abnormal_bone_structure | 1.06642810 |
| 73 | MP0008057_abnormal_DNA_replication | 1.06361594 |
| 74 | * MP0002113_abnormal_skeleton_development | 1.06101672 |
| 75 | MP0000490_abnormal_crypts_of | 1.01798534 |
| 76 | MP0002177_abnormal_outer_ear | 1.00410316 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 1.00314578 |
| 78 | MP0001958_emphysema | 1.00085978 |
| 79 | MP0002089_abnormal_postnatal_growth/wei | 0.99895461 |
| 80 | MP0003300_gastrointestinal_ulcer | 0.99408590 |
| 81 | MP0004381_abnormal_hair_follicle | 0.97742944 |
| 82 | MP0008004_abnormal_stomach_pH | 0.97578175 |
| 83 | MP0004134_abnormal_chest_morphology | 0.96651639 |
| 84 | MP0009379_abnormal_foot_pigmentation | 0.95135339 |
| 85 | MP0005166_decreased_susceptibility_to | 0.94933377 |
| 86 | MP0002102_abnormal_ear_morphology | 0.94600158 |
| 87 | MP0005023_abnormal_wound_healing | 0.92357390 |
| 88 | MP0009763_increased_sensitivity_to | 0.92106631 |
| 89 | MP0003828_pulmonary_edema | 0.91533272 |
| 90 | MP0009333_abnormal_splenocyte_physiolog | 0.91223887 |
| 91 | MP0001542_abnormal_bone_strength | 0.88855084 |
| 92 | MP0006292_abnormal_olfactory_placode | 0.88718145 |
| 93 | MP0000049_abnormal_middle_ear | 0.88109289 |
| 94 | MP0000343_altered_response_to | 0.87933748 |
| 95 | MP0002019_abnormal_tumor_incidence | 0.86777859 |
| 96 | MP0003950_abnormal_plasma_membrane | 0.85253430 |
| 97 | MP0005310_abnormal_salivary_gland | 0.84822245 |
| 98 | MP0003091_abnormal_cell_migration | 0.84803397 |
| 99 | MP0004883_abnormal_blood_vessel | 0.83622376 |
| 100 | MP0000767_abnormal_smooth_muscle | 0.83178303 |
| 101 | MP0001915_intracranial_hemorrhage | 0.81152275 |
| 102 | * MP0000249_abnormal_blood_vessel | 0.81098334 |
| 103 | MP0005275_abnormal_skin_tensile | 0.79359214 |
| 104 | MP0008469_abnormal_protein_level | 0.79308794 |
| 105 | MP0002938_white_spotting | 0.77987944 |
| 106 | MP0005451_abnormal_body_composition | 0.77924035 |
| 107 | MP0002877_abnormal_melanocyte_morpholog | 0.76807013 |
| 108 | * MP0005508_abnormal_skeleton_morphology | 0.74894579 |
| 109 | MP0002928_abnormal_bile_duct | 0.74055921 |
| 110 | MP0009765_abnormal_xenobiotic_induced | 0.73411373 |
| 111 | MP0003045_fibrosis | 0.72524298 |
| 112 | * MP0000163_abnormal_cartilage_morphology | 0.72191101 |
| 113 | MP0005164_abnormal_response_to | 0.71440220 |
| 114 | MP0001663_abnormal_digestive_system | 0.70710449 |
| 115 | * MP0002109_abnormal_limb_morphology | 0.69973321 |
| 116 | MP0005379_endocrine/exocrine_gland_phen | 0.69940224 |
| 117 | MP0002132_abnormal_respiratory_system | 0.69622911 |
| 118 | * MP0002115_abnormal_skeleton_extremities | 0.69495169 |
| 119 | MP0005165_increased_susceptibility_to | 0.69291031 |
| 120 | MP0002332_abnormal_exercise_endurance | 0.66702038 |
| 121 | MP0005058_abnormal_lysosome_morphology | 0.65092130 |
| 122 | MP0008007_abnormal_cellular_replicative | 0.63395539 |
| 123 | MP0005076_abnormal_cell_differentiation | 0.55749279 |
| 124 | MP0008873_increased_physiological_sensi | 0.51994224 |
| 125 | MP0001348_abnormal_lacrimal_gland | 0.51185373 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 5.29685452 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.18852067 |
| 3 | Prostate neoplasm (HP:0100787) | 4.45075414 |
| 4 | Eczematoid dermatitis (HP:0000976) | 3.77678345 |
| 5 | Abnormality of the prostate (HP:0008775) | 3.54016698 |
| 6 | Myositis (HP:0100614) | 3.51955801 |
| 7 | * Spondylolisthesis (HP:0003302) | 3.42703614 |
| 8 | Recurrent skin infections (HP:0001581) | 3.40237777 |
| 9 | Gastrointestinal infarctions (HP:0005244) | 3.39677672 |
| 10 | Agnosia (HP:0010524) | 3.36732002 |
| 11 | Papilledema (HP:0001085) | 3.35340671 |
| 12 | Autoimmune hemolytic anemia (HP:0001890) | 3.32866792 |
| 13 | Panhypogammaglobulinemia (HP:0003139) | 3.26298685 |
| 14 | Chest pain (HP:0100749) | 3.12312656 |
| 15 | Granulocytopenia (HP:0001913) | 3.10112833 |
| 16 | * Metaphyseal dysplasia (HP:0100255) | 3.07567217 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 3.05854915 |
| 18 | Optic neuritis (HP:0100653) | 3.05854915 |
| 19 | Obstructive lung disease (HP:0006536) | 3.05154658 |
| 20 | Chronic obstructive pulmonary disease (HP:0006510) | 3.05154658 |
| 21 | Recurrent fungal infections (HP:0002841) | 3.03113984 |
| 22 | Disinhibition (HP:0000734) | 2.93558500 |
| 23 | Eosinophilia (HP:0001880) | 2.92373268 |
| 24 | IgM deficiency (HP:0002850) | 2.91888435 |
| 25 | Recurrent viral infections (HP:0004429) | 2.87527650 |
| 26 | Abnormality of eosinophils (HP:0001879) | 2.84086200 |
| 27 | Mediastinal lymphadenopathy (HP:0100721) | 2.78099778 |
| 28 | Thrombocytosis (HP:0001894) | 2.77891218 |
| 29 | Acute myeloid leukemia (HP:0004808) | 2.73988406 |
| 30 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.71981091 |
| 31 | Orchitis (HP:0100796) | 2.69739621 |
| 32 | Meningitis (HP:0001287) | 2.67295321 |
| 33 | Urticaria (HP:0001025) | 2.64122935 |
| 34 | Severe combined immunodeficiency (HP:0004430) | 2.62964806 |
| 35 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.56493603 |
| 36 | Pustule (HP:0200039) | 2.55764827 |
| 37 | Protrusio acetabuli (HP:0003179) | 2.47653336 |
| 38 | Asymmetry of the thorax (HP:0001555) | 2.46503203 |
| 39 | * Spinal cord lesions (HP:0100561) | 2.45395957 |
| 40 | * Syringomyelia (HP:0003396) | 2.45395957 |
| 41 | Recurrent cutaneous fungal infections (HP:0011370) | 2.44956502 |
| 42 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.44956502 |
| 43 | Autoimmune thrombocytopenia (HP:0001973) | 2.44048793 |
| 44 | Cellulitis (HP:0100658) | 2.43559604 |
| 45 | Increased IgE level (HP:0003212) | 2.43362590 |
| 46 | Inflammation of the large intestine (HP:0002037) | 2.42487449 |
| 47 | Patchy hypopigmentation of hair (HP:0011365) | 2.41035895 |
| 48 | Abnormality of macrophages (HP:0004311) | 2.41002297 |
| 49 | Spontaneous hematomas (HP:0007420) | 2.36432100 |
| 50 | Gastrointestinal inflammation (HP:0004386) | 2.34953222 |
| 51 | White forelock (HP:0002211) | 2.34054040 |
| 52 | Glomerulopathy (HP:0100820) | 2.32969857 |
| 53 | Peritonitis (HP:0002586) | 2.29566479 |
| 54 | * Absent frontal sinuses (HP:0002688) | 2.29471040 |
| 55 | Hypergammaglobulinemia (HP:0010702) | 2.29314230 |
| 56 | IgG deficiency (HP:0004315) | 2.28249770 |
| 57 | Pulmonary embolism (HP:0002204) | 2.27844140 |
| 58 | Fatigue (HP:0012378) | 2.26999436 |
| 59 | Volvulus (HP:0002580) | 2.26146359 |
| 60 | Keratoconjunctivitis sicca (HP:0001097) | 2.24641816 |
| 61 | Prolonged bleeding time (HP:0003010) | 2.24049788 |
| 62 | Thyroiditis (HP:0100646) | 2.23764682 |
| 63 | Acute lymphatic leukemia (HP:0006721) | 2.23295681 |
| 64 | Abnormality of T cell physiology (HP:0011840) | 2.20791113 |
| 65 | Abnormality of the pleura (HP:0002103) | 2.17502623 |
| 66 | Lip pit (HP:0100267) | 2.17234683 |
| 67 | Colitis (HP:0002583) | 2.16277002 |
| 68 | Gangrene (HP:0100758) | 2.15794462 |
| 69 | Short tibia (HP:0005736) | 2.15443918 |
| 70 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.15270088 |
| 71 | Facial diplegia (HP:0001349) | 2.15243894 |
| 72 | Abnormality of the fingertips (HP:0001211) | 2.14456336 |
| 73 | Abnormality of the pericardium (HP:0001697) | 2.13470361 |
| 74 | Recurrent pneumonia (HP:0006532) | 2.12912079 |
| 75 | * Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.12689590 |
| 76 | Dysostosis multiplex (HP:0000943) | 2.11572749 |
| 77 | Pulmonary fibrosis (HP:0002206) | 2.11469043 |
| 78 | Arterial thrombosis (HP:0004420) | 2.10837881 |
| 79 | Increased IgM level (HP:0003496) | 2.10744615 |
| 80 | Verrucae (HP:0200043) | 2.10528404 |
| 81 | Papilloma (HP:0012740) | 2.10528404 |
| 82 | Recurrent bronchitis (HP:0002837) | 2.10008071 |
| 83 | Inappropriate behavior (HP:0000719) | 2.09517556 |
| 84 | Amelogenesis imperfecta (HP:0000705) | 2.08847909 |
| 85 | Microglossia (HP:0000171) | 2.08258987 |
| 86 | Mesomelia (HP:0003027) | 2.07589177 |
| 87 | Viral hepatitis (HP:0006562) | 2.06372191 |
| 88 | Alveolar cell carcinoma (HP:0006519) | 2.05729496 |
| 89 | Aortic dissection (HP:0002647) | 2.05543435 |
| 90 | Interstitial pulmonary disease (HP:0006530) | 2.05080034 |
| 91 | Limited elbow extension (HP:0001377) | 2.04977943 |
| 92 | Abnormality of incisor morphology (HP:0011063) | 2.04702423 |
| 93 | Premature rupture of membranes (HP:0001788) | 2.04135816 |
| 94 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.03652111 |
| 95 | Chronic otitis media (HP:0000389) | 2.03173546 |
| 96 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.02445997 |
| 97 | * Decreased skull ossification (HP:0004331) | 2.01838506 |
| 98 | Slender build (HP:0001533) | 2.01011050 |
| 99 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.00239974 |
| 100 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.00239974 |
| 101 | Abnormality of glycolipid metabolism (HP:0010969) | 2.00239974 |
| 102 | Keratoconjunctivitis (HP:0001096) | 1.99247763 |
| 103 | Abnormality of the columella (HP:0009929) | 1.98973001 |
| 104 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.97448710 |
| 105 | Pulmonary infiltrates (HP:0002113) | 1.96862662 |
| 106 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.96283492 |
| 107 | Short 4th metacarpal (HP:0010044) | 1.96283492 |
| 108 | Abnormality of lateral ventricle (HP:0030047) | 1.95679290 |
| 109 | Chronic diarrhea (HP:0002028) | 1.95317887 |
| 110 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.95073794 |
| 111 | Amyloidosis (HP:0011034) | 1.94719407 |
| 112 | Vasculitis (HP:0002633) | 1.93116783 |
| 113 | Recurrent lower respiratory tract infections (HP:0002783) | 1.91754445 |
| 114 | Agammaglobulinemia (HP:0004432) | 1.91399181 |
| 115 | Epistaxis (HP:0000421) | 1.91219142 |
| 116 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.90876980 |
| 117 | Osteolytic defects of the hand bones (HP:0009699) | 1.90876980 |
| 118 | Skin rash (HP:0000988) | 1.90185100 |
| 119 | Skin ulcer (HP:0200042) | 1.89835753 |
| 120 | Biconcave vertebral bodies (HP:0004586) | 1.89821734 |
| 121 | Abnormality of the nasal septum (HP:0000419) | 1.89113382 |
| 122 | Petechiae (HP:0000967) | 1.88831525 |
| 123 | Anorexia (HP:0002039) | 1.88785456 |
| 124 | * Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.88384450 |
| 125 | * Craniofacial hyperostosis (HP:0004493) | 1.86701331 |
| 126 | Abnormality of male internal genitalia (HP:0000022) | 1.86410554 |
| 127 | Amaurosis fugax (HP:0100576) | 1.85855368 |
| 128 | Vertebral compression fractures (HP:0002953) | 1.85456095 |
| 129 | Stomatitis (HP:0010280) | 1.85183402 |
| 130 | Abnormality of T cells (HP:0002843) | 1.83822220 |
| 131 | Gingivitis (HP:0000230) | 1.82408072 |
| 132 | * Abnormality of skull ossification (HP:0002703) | 1.81713666 |
| 133 | Abnormal platelet volume (HP:0011876) | 1.80174668 |
| 134 | Gingival bleeding (HP:0000225) | 1.76411681 |
| 135 | Hemoptysis (HP:0002105) | 1.76391559 |
| 136 | Albinism (HP:0001022) | 1.76064615 |
| 137 | Encephalitis (HP:0002383) | 1.75065364 |
| 138 | Dislocated radial head (HP:0003083) | 1.74479808 |
| 139 | Broad face (HP:0000283) | 1.69772794 |
| 140 | Leukocytosis (HP:0001974) | 1.68910125 |
| 141 | Abnormality of the right ventricle (HP:0001707) | 1.67597483 |
| 142 | Abnormality of T cell number (HP:0011839) | 1.67521670 |
| 143 | T lymphocytopenia (HP:0005403) | 1.66520478 |
| 144 | Abnormality of B cell number (HP:0010975) | 1.66230644 |
| 145 | B lymphocytopenia (HP:0010976) | 1.66230644 |
| 146 | Lower limb hyperreflexia (HP:0002395) | 1.65493031 |
| 147 | Osteomyelitis (HP:0002754) | 1.64563811 |
| 148 | Periodontitis (HP:0000704) | 1.64482301 |
| 149 | Cervical subluxation (HP:0003308) | 1.63900376 |
| 150 | Abnormal number of erythroid precursors (HP:0012131) | 1.63277716 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | JAK3 | 3.44819810 |
| 2 | IRAK4 | 3.02895690 |
| 3 | BLK | 2.96120019 |
| 4 | KIT | 2.80875662 |
| 5 | MKNK2 | 2.65860885 |
| 6 | MAP4K1 | 2.60789328 |
| 7 | TXK | 2.51629693 |
| 8 | MAP3K14 | 2.49730159 |
| 9 | IRAK3 | 2.48984310 |
| 10 | FLT3 | 2.47376060 |
| 11 | BRD4 | 2.40453558 |
| 12 | TEC | 2.24664131 |
| 13 | RIPK4 | 2.21026010 |
| 14 | TAOK3 | 2.10784308 |
| 15 | CLK1 | 2.04274817 |
| 16 | ERN1 | 2.03644502 |
| 17 | PRPF4B | 1.95607070 |
| 18 | MKNK1 | 1.94154724 |
| 19 | TNIK | 1.91532115 |
| 20 | CSF1R | 1.83917386 |
| 21 | SIK3 | 1.81653758 |
| 22 | IKBKB | 1.66995815 |
| 23 | BTK | 1.57125338 |
| 24 | FES | 1.52167903 |
| 25 | MAP3K13 | 1.44602113 |
| 26 | STK10 | 1.43965828 |
| 27 | EPHA3 | 1.34066305 |
| 28 | PIK3CG | 1.33363961 |
| 29 | TRPM7 | 1.22402439 |
| 30 | CDK9 | 1.21884475 |
| 31 | SYK | 1.20159425 |
| 32 | IKBKE | 1.19536958 |
| 33 | LCK | 1.18452462 |
| 34 | MAPK7 | 1.17547180 |
| 35 | TYK2 | 1.17367728 |
| 36 | PIK3CA | 1.17289390 |
| 37 | CHUK | 1.14377368 |
| 38 | MAP3K6 | 1.13899232 |
| 39 | BMPR2 | 1.09776485 |
| 40 | TBK1 | 1.02876536 |
| 41 | JAK1 | 0.99963231 |
| 42 | JAK2 | 0.98800922 |
| 43 | HCK | 0.98311691 |
| 44 | CSK | 0.95387464 |
| 45 | SIK2 | 0.95184229 |
| 46 | MAP2K3 | 0.94746843 |
| 47 | ZAP70 | 0.92913346 |
| 48 | GRK7 | 0.92912216 |
| 49 | EIF2AK2 | 0.90260632 |
| 50 | DYRK1A | 0.89863737 |
| 51 | LYN | 0.89425714 |
| 52 | MUSK | 0.89319585 |
| 53 | MOS | 0.86526573 |
| 54 | TAOK2 | 0.86448543 |
| 55 | EPHB1 | 0.86384480 |
| 56 | CDK6 | 0.83570331 |
| 57 | MAP3K3 | 0.83318487 |
| 58 | MAP3K8 | 0.81802916 |
| 59 | NEK9 | 0.80624499 |
| 60 | YES1 | 0.80621466 |
| 61 | RPS6KA6 | 0.79983106 |
| 62 | ITK | 0.79108260 |
| 63 | MAP3K12 | 0.78684812 |
| 64 | MAPK4 | 0.78036464 |
| 65 | TESK2 | 0.77640441 |
| 66 | ADRBK2 | 0.77001601 |
| 67 | MARK3 | 0.76201173 |
| 68 | PIM1 | 0.75398039 |
| 69 | NUAK1 | 0.74669784 |
| 70 | RPS6KC1 | 0.74119344 |
| 71 | RPS6KL1 | 0.74119344 |
| 72 | FGFR3 | 0.73202981 |
| 73 | TGFBR2 | 0.71123707 |
| 74 | NLK | 0.71013347 |
| 75 | PRKCQ | 0.70281460 |
| 76 | SCYL2 | 0.69754247 |
| 77 | MST4 | 0.69668889 |
| 78 | MELK | 0.69079832 |
| 79 | CDK12 | 0.69024505 |
| 80 | MAP2K2 | 0.67827186 |
| 81 | STK11 | 0.67466973 |
| 82 | CASK | 0.66283832 |
| 83 | RPS6KA4 | 0.65316295 |
| 84 | AKT3 | 0.65274107 |
| 85 | CDK4 | 0.64120344 |
| 86 | HIPK2 | 0.63317430 |
| 87 | DMPK | 0.61006619 |
| 88 | NEK6 | 0.58799325 |
| 89 | BMPR1B | 0.56748757 |
| 90 | SIK1 | 0.55539483 |
| 91 | MAP3K5 | 0.54397077 |
| 92 | FRK | 0.53060309 |
| 93 | MAP3K1 | 0.52078405 |
| 94 | ERBB3 | 0.52052109 |
| 95 | FGR | 0.51939048 |
| 96 | MAPK11 | 0.51406070 |
| 97 | ATR | 0.49384423 |
| 98 | IRAK1 | 0.48901146 |
| 99 | DDR2 | 0.47846290 |
| 100 | MATK | 0.47777851 |
| 101 | MAPKAPK2 | 0.47274436 |
| 102 | RPS6KB1 | 0.47063908 |
| 103 | CAMK1G | 0.46113251 |
| 104 | RPS6KA2 | 0.44415822 |
| 105 | GRK6 | 0.44036647 |
| 106 | PTK2B | 0.43826892 |
| 107 | PDK1 | 0.43618786 |
| 108 | ABL1 | 0.43433164 |
| 109 | EIF2AK3 | 0.43413009 |
| 110 | CDK8 | 0.41498305 |
| 111 | MAP3K7 | 0.41362875 |
| 112 | MAPKAPK5 | 0.41118883 |
| 113 | SGK3 | 0.40810648 |
| 114 | PKN1 | 0.40585944 |
| 115 | MAPK12 | 0.40297112 |
| 116 | CDK19 | 0.39021069 |
| 117 | CDK7 | 0.38780216 |
| 118 | PRKD2 | 0.38369453 |
| 119 | PDPK1 | 0.37957510 |
| 120 | * MAPK3 | 0.37813582 |
| 121 | ZAK | 0.37715039 |
| 122 | IGF1R | 0.37393761 |
| 123 | MARK2 | 0.37175574 |
| 124 | SGK2 | 0.37018511 |
| 125 | STK4 | 0.36907017 |
| 126 | MAP3K2 | 0.36356496 |
| 127 | CAMK1D | 0.35798488 |
| 128 | RPS6KB2 | 0.35416501 |
| 129 | BRSK2 | 0.35282349 |
| 130 | TNK2 | 0.35124246 |
| 131 | MAP2K6 | 0.32719035 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.35986237 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.22186377 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.09391097 |
| 4 | Measles_Homo sapiens_hsa05162 | 1.95178724 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.90847659 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.90448300 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.83738542 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.81032023 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.77952423 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.77003193 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.74647483 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 1.69917537 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.59395620 |
| 14 | Malaria_Homo sapiens_hsa05144 | 1.50126158 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.47199691 |
| 16 | Platelet activation_Homo sapiens_hsa04611 | 1.46152420 |
| 17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.39999125 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.38979745 |
| 19 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.38659551 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.35499608 |
| 21 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.33818186 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.32087909 |
| 23 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30976759 |
| 24 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.28608387 |
| 25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.23913097 |
| 26 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.22826887 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.22059621 |
| 28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.20736028 |
| 29 | Hepatitis B_Homo sapiens_hsa05161 | 1.17592233 |
| 30 | Asthma_Homo sapiens_hsa05310 | 1.17506933 |
| 31 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.16934131 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.14543241 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.14233333 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.12071774 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.12045463 |
| 36 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.10452841 |
| 37 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.08825809 |
| 38 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.08703468 |
| 39 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.07128187 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.05983414 |
| 41 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.05763316 |
| 42 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.02659535 |
| 43 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.01577906 |
| 44 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.00789783 |
| 45 | Pertussis_Homo sapiens_hsa05133 | 0.96173811 |
| 46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.95708519 |
| 47 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95347109 |
| 48 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.94655634 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.92200852 |
| 50 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.87316348 |
| 51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.85355968 |
| 52 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.84560527 |
| 53 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.83949425 |
| 54 | Apoptosis_Homo sapiens_hsa04210 | 0.83930739 |
| 55 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81961252 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 0.81289848 |
| 57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.80919539 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.79360340 |
| 59 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.78049779 |
| 60 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.77362106 |
| 61 | Hepatitis C_Homo sapiens_hsa05160 | 0.75761978 |
| 62 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75467941 |
| 63 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.74671301 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.73906233 |
| 65 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72268962 |
| 66 | Focal adhesion_Homo sapiens_hsa04510 | 0.70938583 |
| 67 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.70831007 |
| 68 | HTLV-I infection_Homo sapiens_hsa05166 | 0.70722495 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70623788 |
| 70 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70358352 |
| 71 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.67799384 |
| 72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67690120 |
| 73 | RNA degradation_Homo sapiens_hsa03018 | 0.66957552 |
| 74 | Prostate cancer_Homo sapiens_hsa05215 | 0.66667699 |
| 75 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.64875863 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64077534 |
| 77 | Phagosome_Homo sapiens_hsa04145 | 0.64038927 |
| 78 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.62936853 |
| 79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.62883676 |
| 80 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.61984745 |
| 81 | Morphine addiction_Homo sapiens_hsa05032 | 0.61760912 |
| 82 | Pathways in cancer_Homo sapiens_hsa05200 | 0.61623594 |
| 83 | Salivary secretion_Homo sapiens_hsa04970 | 0.61182940 |
| 84 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60172584 |
| 85 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.59908907 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59008762 |
| 87 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.58345184 |
| 88 | Homologous recombination_Homo sapiens_hsa03440 | 0.57978021 |
| 89 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.57598824 |
| 90 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.57144717 |
| 91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56420910 |
| 92 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.56281974 |
| 93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56255200 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55666380 |
| 95 | Lysosome_Homo sapiens_hsa04142 | 0.55446191 |
| 96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55284440 |
| 97 | Legionellosis_Homo sapiens_hsa05134 | 0.54922844 |
| 98 | Melanoma_Homo sapiens_hsa05218 | 0.54498688 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54200556 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.54077088 |
| 101 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.52671954 |
| 102 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.52509667 |
| 103 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51732027 |
| 104 | Long-term potentiation_Homo sapiens_hsa04720 | 0.50885284 |
| 105 | Circadian entrainment_Homo sapiens_hsa04713 | 0.50838983 |
| 106 | Ribosome_Homo sapiens_hsa03010 | 0.50751795 |
| 107 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50687203 |
| 108 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50562958 |
| 109 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.50213246 |
| 110 | Amoebiasis_Homo sapiens_hsa05146 | 0.49826517 |
| 111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49254244 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48509155 |
| 113 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.47694979 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.46159885 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46151242 |
| 116 | Bladder cancer_Homo sapiens_hsa05219 | 0.41724747 |
| 117 | Colorectal cancer_Homo sapiens_hsa05210 | 0.41639644 |
| 118 | Endocytosis_Homo sapiens_hsa04144 | 0.41254229 |
| 119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41084288 |
| 120 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40794827 |
| 121 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.40158607 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36631523 |
| 123 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34844011 |
| 124 | Glioma_Homo sapiens_hsa05214 | 0.32744984 |
| 125 | Endometrial cancer_Homo sapiens_hsa05213 | 0.29769302 |
| 126 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25586446 |

